Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer

Clinical trial NCT06617923 · RECRUITING

Trial details

NCT number: NCT06617923
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovary Cancer Fallopian Tube Cancer Primary Peritoneal Cavity Cancer

Start date: 2025-02-06
Primary completion: 2027-10-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.